Search Within

Victoria M Richon

Formats
  1. Journal Article (49)
  2. Meeting Abstract (37)
  3. Book Section (4)
  4. Conference Paper (1)
Groups
  1. Surgery (11)
  2. Center for Hematologic Malignancies (10)
  3. Department of Medicine (10)
  4. Solid Tumor Oncology Division (8)
  5. Genitourinary Oncology Service (6)
  6. Pediatric Leukemia (6)

More Groups

People
  1. Paul Marks (77)
  2. Richard Rifkind (76)
  3. Xianbo Zhou (11)
  4. Carlos Cordon-Cardo (10)
  5. Hiroaki Kiyokawa (9)
  6. Gisela Venta-Perez (8)

More People

Years
  1. 2004 (2)
  2. 2003 (3)
  3. 2002 (6)
  4. 2001 (11)
  5. 2000 (11)
  6. 1999 (11)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (20)
  2. Proceedings of the National Academy of Sciences of the United States of America (11)
  3. Blood (8)
  4. Cancer Research (7)
  5. Clinical Cancer Research (6)
  6. Anticancer Research (5)

More Publications

Publishers
  1. American Association for Cancer Research (35)
  2. National Academy of Sciences (11)
  3. American Society of Hematology (8)
  4. International Institute of Anticancer Research (5)
  5. Nature Publishing Group (4)
  6. Elsevier Science, Inc. (3)

More Publishers

Results (91)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cloning of the cDNA encoding phenylalanyl tRNA synthetase regulatory α-subunit-like protein whose expression is down-regulated during differentiation
    Journal Article

    Zhou, X.; Richon, V. M.; Ngo, L.; Rifkind, R. A.; Marks, P. A.
    Gene (1999)

    Fulltext@MSK | Save
  • Hybrid polar inducers of transformed cell differentiation/apoptosis. From the cell to the clinic
    Journal Article

    Marks, P. A.; Richon, V. M.; Breslow, R.; Rifkind, R. A.
    Comptes Rendus de l'Academie des Sciences - Serie 3 (1999)

    Fulltext@MSK | Save
  • Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
    Journal Article

    Glick, R. D.; Swendeman, S. L.; Coffey, D. C.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; La Quaglia, M. P.
    Cancer Research (1999)

    Fulltext@MSK | Save
  • Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA)
    Journal Article

    Cohen, L. A.; Amin, S.; Marks, P. A.; Rifkind, R. A.; Desai, D.; Richon, V. M.
    Anticancer Research (1999)

    Fulltext@MSK | Save
  • Genotypic and phenotypic characterization of E2F1 in bladder cancer
    Meeting Abstract

    Rabbani, F.; Richon, V. M.; Lu, M.; Orlow, I.; Drobnjak, M.; Zhang, Z. F.; Cordon-Cardo, C.
    Proceedings of the American Association for Cancer Research Annual Meeting (1998)

    Fulltext@MSK | Save
  • Hybrid polar compounds selected for cytodifferentiation activity inhibit histone deacetylase activity
    Meeting Abstract

    Richon, V. M.; Ngo, L.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1998)

    Fulltext@MSK | Save
  • Identification of a potential target for hybrid polar cytodifferentiation agents
    Meeting Abstract

    Webb, Y.; Ngo, L.; Richon, V. M.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1998)

    Fulltext@MSK | Save
  • The hybrid polar cytodifferentiation agent suberoylanilide hydroxamic acid (SAHA) is a potent inhibitor of histone deacetylase activity
    Meeting Abstract

    Richon, V. M.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
    Blood (1998)

    Fulltext@MSK | Save
  • Transcription therapy for cancer: Effects of histone deacetylase (HDAC) inhibitors on proliferation, apoptosis and differentiation of leukemic cell lines
    Meeting Abstract

    He, L. Z.; Tolentino, T.; Warrell, R. P.; Zelent, A.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • The second-generation hybrid polar compound SAHA is a potent inducer of apoptosis in human myelomonocytic leukemia cells (U937)
    Meeting Abstract

    Vrana, J. A.; Wang, Z.; Jarvis, W. D.; Johnson, C. R.; Fisher, P. B.; Richon, V.; Grant, S.
    Blood (1998)

    Fulltext@MSK | Save